Avi Levine

Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation

Chimerism of the Transplanted Heart

Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation

Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices

Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation

Cardiovascular Risk Reduction in High-Risk Pediatric Patients

Effect of Pravastatin on Outcomes after Cardiac Transplantation

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

Gastric bypass in morbidly obese kidney transplant recipients

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Task force 5: Complications

The Impact of Transvenous Lead Extraction on Tricuspid Valve Function

Persistence of interstitial inflammation after episodes of cardiac rejection associated with systemic infection.

Natural history and predictors of obesity after orthotopic heart transplantation.